Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing

NCT04554121 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT04554121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04554121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing
Lead sponsor
Columbia University
Phase
Not applicable
Overall status
Completed
Start date
December 14, 2020
Completion date
December 8, 2025
Enrollment
194 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia